July 23, 2016 3:58 PM ET

Pharmaceuticals

Company Overview of Braeburn Pharmaceuticals, Inc.

Executive Profile

Frank E. Young M.D., Ph.D.

Executive Vice President of Clinical and Regulatory Affairs, Braeburn Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 12 different industries.

See Board Relationships
----

Background

Dr. Frank E. Young, M.D., Ph.D. has been an Executive Vice President of Clinical and Regulatory Affairs at Braeburn Pharmaceuticals, Inc. since September 2013. He serves as an Advisor to the Board of Directors for Bioventus. Dr. Young is an Adjunct Partner at Essex Woodlands Health Ventures since joining in March 2002. He serves as Special Advisor of Panacea Pharmaceuticals, Inc. He served as a Venture Partner at Apple Tree Partners. He served as Scientific Advisor of ...

Corporate Headquarters

47 Hulfish Street
Princeton, New Jersey 08542

United States

Phone: 609-751-5375
Fax: --

Board Members Memberships

Director
Independent Director, Member of Audit Committee, Member of Nominating Committee and Member of Compensation Committee

Education

PhD
Case Western Reserve University
Unknown/Other Education
Union College
MD
SUNY Upstate Medical University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Braeburn Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.